
Photo: LVM3 launch, Sriharikota, ISRO, GODL-India
APPSC Group-I Mains 2025 · Paper V
2025 Paper V · Q13(a): model answer
Science, Technology & Environmental Issues · Biotechnology and health. Held in May 2025 (Notification 12/2023).
Describe the components and functioning of a vaccine.
Syllabus: Biotechnology and health · Health and diseases
AntigenAdjuvantImmunological memoryHerd immunity
A vaccine is a biological preparation that trains the immune system to recognise a pathogen without causing the disease. It contains a harmless form, part or genetic blueprint of the microbe, the antigen, plus ingredients that make it safe, stable and effective. By creating memory cells it gives long-lasting active immunity, and when enough people are vaccinated, herd immunity protects those who are not.
1. Components of a vaccine
- Antigen (active ingredient): a weakened live microbe, a killed microbe, a purified protein or sugar, an inactivated toxin (toxoid), or genetic code (mRNA, DNA or a viral vector) that makes the body's cells produce the antigen.
- Adjuvant: boosts and prolongs the immune response so that less antigen is needed; aluminium salts (alum) are the commonest.
- Stabilisers: sugars, amino acids or gelatin keep the vaccine potent during storage and transport.
- Preservatives: such as 2-phenoxyethanol or thiomersal, prevent contamination in multi-dose vials.
- Other contents: a diluent (sterile water or saline), buffers, and traces of production materials reduced to safe limits; a cold chain of 2–8 °C protects potency.
| Type | Antigen | Examples |
|---|---|---|
| Live attenuated | Weakened live microbe | BCG, oral polio, measles–rubella, Rotavac |
| Inactivated | Killed whole microbe | IPV, Covaxin, rabies |
| Subunit or recombinant | A purified protein | Hepatitis B, HPV, Corbevax |
| Conjugate | Sugar linked to a carrier protein | Hib, pneumococcal, typhoid conjugate |
| Toxoid | Inactivated toxin | Tetanus, diphtheria |
| Genetic | mRNA, DNA or a viral vector | GEMCOVAC, ZyCoV-D, Covishield |
2. How a vaccine works
- Innate alarm: the antigen and adjuvant cause mild local inflammation; antigen-presenting cells carry the antigen to the lymph nodes.
- Adaptive response: helper (CD4) T cells activate B cells, which become plasma cells making specific antibodies (humoral immunity); cytotoxic (CD8) T cells learn to kill infected cells (cell-mediated immunity).
- Memory: memory B and T cells persist for years; on real exposure they respond within days, before disease sets in. The first dose gives a slow, mainly IgM response; boosters give a rapid, high IgG response.
- Herd immunity: above a threshold, about 95% for highly contagious measles, transmission chains break; India was certified polio-free in 2014.
3. India's vaccination effort
- Programmes: the Universal Immunisation Programme (1985) offers free vaccines against 12 diseases; Mission Indradhanush (2014) reaches left-out children; U-WIN keeps digital records; HPV vaccination for girls aged 14 began on 28 February 2026.
- Production: India makes nearly 60% of the world's vaccines, including indigenous Covaxin, ZyCoV-D and CERVAVAC.
- Challenges: vaccine hesitancy, zero-dose children in urban slums and remote areas, and cold-chain gaps.
A vaccine combines an antigen with adjuvants and stabilisers to build immune memory safely; wider coverage, new platforms such as mRNA and a strong cold chain keep it the most cost-effective tool of public health.
The other choice in Q13
Answer either one in the exam.
- Q13(b)Define genetic engineering. Explain its applications in agriculture and medicine.
10 marks · Biotechnology and health · Biotechnology
Every model answer on these pages is free to read. The Tool Kit adds four PDF books for Mains Papers I–IV: every previous question sorted by syllabus, with practice questions. It is in the ₹149 All-in-One Pass, with every previous paper of every exam on the site, practice quizzes, timed tests, mock test series and study books.
₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking